CARIS LIFE SCIENCES, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
CARIS LIFE SCIENCES, INC. (CAI) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 29.69 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-05
- CARIS LIFE SCIENCES, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 29.69M shares, a 6.38% increase year-over-year.
- CARIS LIFE SCIENCES, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 31.10M shares, a 85.55% decline year-over-year.
- CARIS LIFE SCIENCES, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 1.62M shares, a 99.24% decline year-over-year.
- CARIS LIFE SCIENCES, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 27.91M shares.
- CARIS LIFE SCIENCES, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 26.55M shares, a 87.54% decline from fiscal 2024.
- CARIS LIFE SCIENCES, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 213.00M shares, a 0.22% increase from fiscal 2023.
- CARIS LIFE SCIENCES, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 212.54M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|
| 2026-06-30 | 29.69M shares 10-Q · filed 2026-08-05 | 29.69M shares 10-Q · filed 2026-08-05 | ||
| 2026-03-31 | 31.10M shares 10-Q · filed 2026-05-08 | |||
| 2025-12-31 | 26.55M shares 10-K · filed 2026-03-03 | |||
| 2025-09-30 | 1.62M shares 10-Q · filed 2025-11-05 | 27.06M shares 10-Q · filed 2025-11-05 | ||
| 2025-06-30 | 27.91M shares 10-Q · filed 2026-08-05 | 27.91M shares 10-Q · filed 2026-08-05 | ||
| 2025-03-31 | 215.25M shares 10-Q · filed 2026-05-08 | |||
| 2024-12-31 | 213.00M shares 10-K · filed 2026-03-03 | |||
| 2024-09-30 | 212.43M shares 10-Q · filed 2025-11-05 | 212.43M shares 10-Q · filed 2025-11-05 | ||
| 2024-06-30 | 212.15M shares 10-Q · filed 2025-08-12 | |||
| 2023-12-31 | 212.54M shares 10-K · filed 2026-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |